Eloxx Pharmaceuticals, Inc. (ELOX) vs TELA Bio, Inc. (TELA)
A side-by-side comparison of Eloxx Pharmaceuticals, Inc. and TELA Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELOX
Eloxx Pharmaceuticals, Inc.
$15.05HealthcareDelayed quote: Oct 6, 2026, 3:08 PM EDT
TELA
TELA Bio, Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
Total return — ELOX vs TELA
growth of $100 · dividends reinvested · last 1yELOX +40.0% (+40.0%/yr)TELA +21.9% (+21.9%/yr)ELOX compounded faster over this window
ELOX TELA
Metrics side by side
Total return (annualized)
| Metric | ELOX | TELA |
|---|---|---|
| Total return (1Y) | N/A | -26.81% |
| Total return CAGR (3Y) | N/A | -45.69% |
| Total return CAGR (5Y) | N/A | -38.71% |
ELOX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.